| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.064 | 0.4 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.039 | 0.4 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |